PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
Top Cited Papers
Open Access
- 22 December 2010
- journal article
- Published by Springer Science and Business Media LLC in Cell Communication and Signaling
- Vol. 8 (1), 31
- https://doi.org/10.1186/1478-811x-8-31
Abstract
The normal function of poly (ADP-ribose) polymerase-1 (PARP-1) is the routine repair of DNA damage by adding poly (ADP ribose) polymers in response to a variety of cellular stresses. Recently, it has become widely appreciated that PARP-1 also participates in diverse physiological and pathological functions from cell survival to several forms of cell death and has been implicated in gene transcription, immune responses, inflammation, learning, memory, synaptic functions, angiogenesis and aging. In the CNS, PARP inhibition attenuates injury in pathologies like cerebral ischemia, trauma and excitotoxicity demonstrating a central role of PARP-1 in these pathologies. PARP-1 is also a preferred substrate for several 'suicidal' proteases and the proteolytic action of suicidal proteases (caspases, calpains, cathepsins, granzymes and matrix metalloproteinases (MMPs)) on PARP-1 produces several specific proteolytic cleavage fragments with different molecular weights. These PARP-1 signature fragments are recognized biomarkers for specific patterns of protease activity in unique cell death programs. This review focuses on specific suicidal proteases active towards PARP-1 to generate signature PARP-1 fragments that can identify key proteases and particular forms of cell death involved in pathophysiology. The roles played by some of the PARP-1 fragments and their associated binding partners in the control of different forms of cell death are also discussed.Keywords
This publication has 156 references indexed in Scilit:
- Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncationExperimental Neurology, 2009
- Cathepsin G-mediated enhanced TGF-β signaling promotes angiogenesis via upregulation of VEGF and MCP-1Cancer Letters, 2009
- Inhibition of matrix metalloproteinase-2 by PARP inhibitorsBiochemical and Biophysical Research Communications, 2009
- Calcium dysregulation induces apoptosis-inducing factor release: Cross-talk between PARP-1- and calpain- signaling pathwaysExperimental Neurology, 2009
- Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarctionMolecular and Cellular Biochemistry, 2008
- Granzyme A Cleaves a Mitochondrial Complex I Protein to Initiate Caspase-Independent Cell DeathCell, 2008
- Distinct Mechanisms of Apoptosis-Induced Compensatory Proliferation in Proliferating and Differentiating Tissues in the Drosophila EyeDevelopmental Cell, 2008
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2007
- Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesisBiochemical and Biophysical Research Communications, 2006
- The PARP superfamilyBioEssays, 2004